症例は46歳,男性。主訴は腰背部痛。胸腰椎に圧迫骨折を伴った多発骨転移,遠隔リンパ節転移を伴う進行胃癌の診断に対してS-1/CDDP併用療法を8コース施行し...
進行再発胃癌の標準レジメンであるs-1+ CDDP併用療法は,入院治療で行われることが一般的であつたが,最近では 外来治療が可能となってきている。外来治療の実現のためには支持療法の強化が必要であり,われわれは支持療法を包括した クリニカルパス(パス)を作成することにより実施した。薬剤師の専...
We have developed a triplet-drug combination regimen consisting of docetaxel, CDDP, and S-1 (DCS) and recently carried out a feasibility study of DCS-trastuzumab (DCS-T) for patients with HER2-positive unresectable metastatic gastric cancer. We reported that both regimens are associated with a ...
A review of the published literature was undertaken to ascertain the trends in treatment schedules of combination of an oral fluorouracil derivative S-1 with low-dose CDDP (25 mg/m2 or less) for un-resectable and recurrent gastric cancer. The case reports demonstrated as follows: S-1 was give...
The group of 14 patients with advanced gastric cancer received combination chemotherapy with S-1 and cis-diamminedichloroplatinum (CDDP) as a neoadjuvant chemotherapy (NAC). This regimen was repeated every 5 weeks for a total of 2–5 cycles. The 25 patients with Stage III gastric cancer was ...
ISY4-7Conversion therapy using docetaxel/CDDP/S-1 (DCS) in inoperable, metastatic gastric cancer patients Y Sato - 《Annals of Oncology》 被引量: 0发表: 2015年 Toxicity of high-dose radiotherapy combined with daily cisplatin in non-small cell lung cancer: results of the EORTC 08912 phase I...
Here we present a valuable case of advanced gastric cancer with synchronous liver metastasis, which was treated by S-1 + CDDP and S-1 therapy without surgery. A 58-year-old man was referred to our hospital with a diagnosis of advanced gastric cancer with liver metastasis at stage of ...
経口摂取不能の進行胃癌患者に対して腸瘻を造設し,腸瘻からS-1投与を行うことにより治療および栄養管理も可能であることから,患者のQOLの改善が見込めると考えられる。 机译:由于近期的进展,不可切除的晚期胃癌的化学疗法显示出很高的治疗效果,但是尚未建立用于胃癌的标准化学疗法。我们报告了一例无法...
656PTREATMENT STRATEGY FOR CONVERSION THERAPY USING DOCETAXEL/CDDP/S-1 (DCS) OR DCS-TRASTUZUMAB (DCS-T) ACCORDING TO HER2 STATUS IN METASTATIC GASTRIC CANCER PATIENTS 喜欢 0 阅读量: 16 作者: Y Sato,H Ohnuma,T Takayama,T Sagawa,M Hirakawa,Y Sato,Y Takahashi,M Takahashi,M Maeda,S Katsuki...
Early endpoints of a randomized phase II trial of preoperative chemotherapy with S-1/CDDP with or without trastuzumab followed by surgery for HER2-positive resectable gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1301C (...